As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Overstated — Phase II Clinical Trial Advancing Toward the Second Part, Says ...

The NV-387 Oral Gummies as a Treatment for Ebola Phase II Clinical Trial in DRC is divided into two parts. The first part, Phase IIA, is designed to evaluate dosing regimens based…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)